Wednesday, February 10, 2010, 4:18am EST - Canadian Markets open in 5 hours and 12 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Nektar Therapeutics (NKTR)

On Feb 9: 11.71 USD   0.00 (0.00%)  
MORE ON NKTR
Quotes
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
HereIncome Statement
Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
PERIOD ENDING 30-Sep-09 30-Jun-09 31-Mar-09 31-Dec-08
Total Revenue 10,223   12,988   9,711   28,353  
Cost of Revenue 5,691   10,231   5,099   10,196  
Gross Profit 4,532   2,757   4,612   18,157  
Operating Expenses
Research Development 23,474   24,150   23,890   45,279  
Selling General and Administrative 9,917   9,087   11,020   14,546  
Non Recurring -   -   -   (68,114)
Others -   -   -   (710)
Total Operating Expenses -   -   -   (8,999)
Operating Income or Loss (28,859) (30,480) (30,298) 27,156  
Income from Continuing Operations
Total Other Income/Expenses Net 680   1,153   1,695   51,641  
Earnings Before Interest And Taxes (28,179) (29,327) (28,603) 78,797  
Interest Expense 2,928   2,948   3,337   3,357  
Income Before Tax (31,107) (32,275) (31,940) 75,440  
Income Tax Expense (140) (206) (133) (1,342)
Minority Interest -   -   -   -  
Net Income From Continuing Ops (30,967) (32,069) (31,807) 76,782  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (30,967) (32,069) (31,807) 76,782  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares ($30,967) ($32,069) ($31,807) $76,782  

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Income Statement for Another Symbol:
Symbol Lookup
Latest News Canadian Indices


Reuters offers more in-depth Company Research , Stock Screening , and Risk Alerts on over 10,000 U.S. Equities.